Title: FDA's reviews of new drugs
Subtitle: changes needed in process for reviewing and reporting on clinical studies : report to the ranking minority member, Special Committee on Aging, U.S. Senate
Subjects: Drugs, United States. Food and Drug Administration. Division of Scientific Investigations, Testing, United States
Places: United States